Search
for
Sort by
Research 151–180 of 1000+
- Neuroendocrinology of the hair follicle: principles and clinical perspectives
- FASCE, benefit of spironolactone for treating acne of adult female: study protocol for a randomized double-blind trial
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- KCNQ Potassium Channels Modulate Sensitivity of Skin Down-hair (D-hair) Mechanoreceptors
- Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
- An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- Increased plasma renin by vasodilators promotes the progression of abdominal aortic aneurysm
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- The JAK/STAT signaling pathway: from bench to clinic
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
- New effects of caffeine on corticotropin‐releasing hormone (CRH)‐induced stress along the intrafollicular classical hypothalamic–pituitary–adrenal (HPA) axis (CRH‐R1/2, IP<sub>3</sub>‐R, ACTH, MC‐R2) and the neurogenic non‐HPA axis (substance P, p75<sup>NTR</sup>and TrkA) in<i>ex vivo</i>human male androgenetic scalp hair follicles
- Spironolactone
- Repurposing of approved cardiovascular drugs
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Is COVID-19 Gender-sensitive?
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Spironolactone May Reduce the Risk of Incident Rosacea
- Poster Abstracts
- A consideration when interpreting outpatient data
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia